11/4/2025

Janusmed sex and gender

Janusmed sex and gender – lithium carbonate

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Lithium

Lithium

Class : A

Show all info

Print

Contact us

  1. Karanti A, Bobeck C, Osterman M, Kardell M, Tidemalm D, Runeson B et al. Gender differences in the treatment of patients with bipolar disorder: a study of 7354 patients. J Affect Disord. 2015;174:303-9.

  2. Viguera AC, Tondo L, Baldessarini RJ. Sex differences in response to lithium treatment. Am J Psychiatry. 2000;157:1509-11.

  3. Viguera AC, Baldessarini RJ, Tondo L. Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disord. 2001;3:245-52.

  4. Benedetti A, Fagiolini A, Casamassima F, Mian MS, Adamovit A, Musetti L et al. Gender differences in bipolar disorder type 1: a 48-week prospective follow-up of 72 patients treated in an Italian tertiary care center. J Nerv Ment Dis. 2007;195:93-6.

  5. Özerdem A, Tunca Z, Çımrın D, Hıdıroğlu C, Ergör G. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment. Bipolar Disord. 2014;16:72-82.

  6. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism Prevalence and risk factors. Br J Psychiatry. 1999;175:336-9.

  7. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci. 1999;24:227-33.

  8. Close H, Reilly J, Mason JM, Kripalani M, Wilson D, Main J et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014;9:e90169.

  9. Rybakowski JK, Abramowicz M, Drogowska J, Chłopocka-Woźniak M, Michalak M, Czekalski S. Screening for the markers of kidney damage in men and women on long-term lithium treatment. Med Sci Monit. 2012;18:CR656-60.

  10. Bocchetta A, Ardau R, Carta P, Ligas F, Sardu C, Pani A et al. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33.

  11. Kinahan JC, NiChorcorain A, Cunningham S, Freyne A, Cooney C, Barry S et al. Risk factors for polyuria in a cross-section of community psychiatric lithium-treated patients. Bipolar Disord. 2015;17:50-62.

  12. Zaidan M, Stucker F, Stengel B, Vasiliu V, Hummel A, Landais P et al. Increased risk of solid renal tumors in lithium-treated patients. Kidney Int. 2014;86:184-90.

  13. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Lithium and renal and upper urinary tract tumors - results from a nationwide population-based study. Bipolar Disord. 2015;17:805-13.

  14. Henry C. Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences. J Psychiatry Neurosci. 2002;27:104-7.

  15. Lithionit (litium). Summary of Product Characteristics. Medical Products Agency (MPA); 2017.

  16. Bramness JG, Weitoft GR, Hallas J. Use of lithium in the adult populations of Denmark, Norway and Sweden. J Affect Disord. 2009;118:224-8.

  17. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362:2185-93.

  18. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2016 [cited 2017-06-20.]

  1. Karanti A, Bobeck C, Osterman M, Kardell M, Tidemalm D, Runeson B et al. Gender differences in the treatment of patients with bipolar disorder: a study of 7354 patients. J Affect Disord. 2015;174:303-9.
  2. Viguera AC, Tondo L, Baldessarini RJ. Sex differences in response to lithium treatment. Am J Psychiatry. 2000;157:1509-11.
  3. Viguera AC, Baldessarini RJ, Tondo L. Response to lithium maintenance treatment in bipolar disorders: comparison of women and men. Bipolar Disord. 2001;3:245-52.
  4. Benedetti A, Fagiolini A, Casamassima F, Mian MS, Adamovit A, Musetti L et al. Gender differences in bipolar disorder type 1: a 48-week prospective follow-up of 72 patients treated in an Italian tertiary care center. J Nerv Ment Dis. 2007;195:93-6.
  5. Özerdem A, Tunca Z, Çımrın D, Hıdıroğlu C, Ergör G. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment. Bipolar Disord. 2014;16:72-82.
  6. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism Prevalence and risk factors. Br J Psychiatry. 1999;175:336-9.
  7. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci. 1999;24:227-33.
  8. Close H, Reilly J, Mason JM, Kripalani M, Wilson D, Main J et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLoS One. 2014;9:e90169.
  9. Rybakowski JK, Abramowicz M, Drogowska J, Chłopocka-Woźniak M, Michalak M, Czekalski S. Screening for the markers of kidney damage in men and women on long-term lithium treatment. Med Sci Monit. 2012;18:CR656-60.
  10. Bocchetta A, Ardau R, Carta P, Ligas F, Sardu C, Pani A et al. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med. 2013;11:33.
  11. Kinahan JC, NiChorcorain A, Cunningham S, Freyne A, Cooney C, Barry S et al. Risk factors for polyuria in a cross-section of community psychiatric lithium-treated patients. Bipolar Disord. 2015;17:50-62.
  12. Zaidan M, Stucker F, Stengel B, Vasiliu V, Hummel A, Landais P et al. Increased risk of solid renal tumors in lithium-treated patients. Kidney Int. 2014;86:184-90.
  13. Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Lithium and renal and upper urinary tract tumors - results from a nationwide population-based study. Bipolar Disord. 2015;17:805-13.
  14. Henry C. Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences. J Psychiatry Neurosci. 2002;27:104-7.
  15. Lithionit (litium). Summary of Product Characteristics. Medical Products Agency (MPA); 2017.
  16. Bramness JG, Weitoft GR, Hallas J. Use of lithium in the adult populations of Denmark, Norway and Sweden. J Affect Disord. 2009;118:224-8.
  17. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362:2185-93.
  18. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2016 [cited 2017-06-20.]